Do MS patients who came down with COVID and took Paxlovid have less of a chance of a MS flare-up than MS patients who had COVID and didn’t take Paxlovid?
How might the COVID-19 vaccine contribute to the onset or exacerbation of autoimmune diseases like multiple sclerosis, particularly in regions where MS is less prevalent, such as Ecuador?
Are people with MS who received the Johnson & Johnson Covid 19 vaccine and got blood clots due to it more susceptible to getting blood clots in the future?
